Annual CFF
$41.82 M
+$41.12 M+5807.20%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual cash flow from financing activities is $41.82 million, with the most recent change of +$41.12 million (+5807.20%) on December 31, 2023.
- During the last 3 years, OMGA annual CFF has fallen by -$6.79 million (-13.98%).
- OMGA annual CFF is now -84.01% below its all-time high of $261.54 million, reached on December 31, 2021.
Performance
OMGA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$1.44 M
-$331.00 K-29.74%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly cash flow from financing activities is -$1.44 million, with the most recent change of -$331.00 thousand (-29.74%) on September 30, 2024.
- Over the past year, OMGA quarterly CFF has dropped by -$374.00 thousand (-34.95%).
- OMGA quarterly CFF is now -101.12% below its all-time high of $128.71 million, reached on September 30, 2021.
Performance
OMGA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$2.00 M
-$1.44 M-253.71%
September 30, 2024
Summary
- As of February 7, 2025, OMGA TTM cash flow from financing activities is -$2.00 million, with the most recent change of -$1.44 million (-253.71%) on September 30, 2024.
- Over the past year, OMGA TTM CFF has dropped by -$2.77 million (-361.36%).
- OMGA TTM CFF is now -100.77% below its all-time high of $261.54 million, reached on December 31, 2021.
Performance
OMGA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OMGA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5807.2% | -35.0% | -361.4% |
| 3 y3 years | -14.0% | -35.0% | -361.4% |
| 5 y5 years | +249.0% | -35.0% | -361.4% |
OMGA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.0% | +5807.2% | -103.6% | at low | -100.8% | at low |
| 5 y | 5-year | -84.0% | +5807.2% | -101.1% | at low | -100.8% | at low |
| alltime | all time | -84.0% | +5807.2% | -101.1% | at low | -100.8% | at low |
Omega Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.44 M(+29.7%) | -$2.00 M(+253.7%) |
| Jun 2024 | - | -$1.11 M(+4.0%) | -$566.00 K(-173.9%) |
| Mar 2024 | - | -$1.07 M(-165.8%) | $766.00 K(-98.2%) |
| Dec 2023 | $41.82 M(+5807.2%) | $1.63 M(<-9900.0%) | $41.82 M(+2.5%) |
| Sep 2023 | - | -$8000.00(-103.7%) | $40.78 M(-0.0%) |
| Jun 2023 | - | $219.00 K(-99.5%) | $40.80 M(+0.5%) |
| Mar 2023 | - | $39.99 M(+6723.7%) | $40.61 M(+5636.2%) |
| Dec 2022 | $708.00 K | $586.00 K(>+9900.0%) | $708.00 K(-90.5%) |
| Sep 2022 | - | $4000.00(-88.6%) | $7.42 M(-94.6%) |
| Jun 2022 | - | $35.00 K(-57.8%) | $136.13 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $83.00 K(-98.9%) | $136.21 M(-47.9%) |
| Dec 2021 | $261.54 M(+437.9%) | $7.29 M(-94.3%) | $261.54 M(+2.9%) |
| Sep 2021 | - | $128.71 M(>+9900.0%) | $254.29 M(+91.0%) |
| Jun 2021 | - | $118.00 K(-99.9%) | $133.10 M(-3.5%) |
| Mar 2021 | - | $125.41 M(>+9900.0%) | $137.99 M(+183.8%) |
| Dec 2020 | $48.62 M(+305.7%) | $46.00 K(-99.4%) | $48.62 M(+0.1%) |
| Sep 2020 | - | $7.53 M(+50.6%) | $48.57 M(+18.3%) |
| Jun 2020 | - | $5.00 M(-86.1%) | $41.04 M(+13.9%) |
| Mar 2020 | - | $36.05 M | $36.05 M |
| Dec 2019 | $11.98 M | - | - |
FAQ
- What is Omega Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Omega Therapeutics?
- What is Omega Therapeutics annual CFF year-on-year change?
- What is Omega Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Omega Therapeutics?
- What is Omega Therapeutics quarterly CFF year-on-year change?
- What is Omega Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Omega Therapeutics?
- What is Omega Therapeutics TTM CFF year-on-year change?
What is Omega Therapeutics annual cash flow from financing activities?
The current annual CFF of OMGA is $41.82 M
What is the all time high annual CFF for Omega Therapeutics?
Omega Therapeutics all-time high annual cash flow from financing activities is $261.54 M
What is Omega Therapeutics annual CFF year-on-year change?
Over the past year, OMGA annual cash flow from financing activities has changed by +$41.12 M (+5807.20%)
What is Omega Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of OMGA is -$1.44 M
What is the all time high quarterly CFF for Omega Therapeutics?
Omega Therapeutics all-time high quarterly cash flow from financing activities is $128.71 M
What is Omega Therapeutics quarterly CFF year-on-year change?
Over the past year, OMGA quarterly cash flow from financing activities has changed by -$374.00 K (-34.95%)
What is Omega Therapeutics TTM cash flow from financing activities?
The current TTM CFF of OMGA is -$2.00 M
What is the all time high TTM CFF for Omega Therapeutics?
Omega Therapeutics all-time high TTM cash flow from financing activities is $261.54 M
What is Omega Therapeutics TTM CFF year-on-year change?
Over the past year, OMGA TTM cash flow from financing activities has changed by -$2.77 M (-361.36%)